PLX Change in Working Capital
Protalix Biotherapeutics Inc · Change in Working Capital
PLX Change in Working Capital
Latest reported-$15.56Mperiod ending
PLX Quarterly Change in Working Capital ($0.00 → -$15.56M)
Quarterly change in working capital
High-resolution chart · PNG
PLX change in working capital history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -15,559,000 | |
| 2,538,000 | |
| 5,776,000 | |
| -7,136,000 | |
| -6,899,000 | |
| -1,840,000 | |
| -3,447,000 | |
| -1,674,000 | |
| -2,152,000 | |
| 8,084,000 | |
| 6,299,000 | |
| -6,069,000 | |
| -11,542,000 | |
| -702,000 | |
| 300,000 | |
| -6,327,000 | |
| -1,377,000 | |
| -4,611,000 | |
| 492,000 | |
| -251,000 | |
| 15,875,000 | |
| -6,215,000 | |
| -10,606,000 | |
| -1,103,000 | |
| -5,148,000 | |
| -10,273,000 | |
| -5,308,000 | |
| -1,303,000 | |
| 1,183,000 | |
| -1,407,000 | |
| -15,465,000 | |
| 28,171,000 | |
| 2,226,000 | |
| -1,407,000 | |
| 29,943,000 | |
| -1,954,000 | |
| 2,603,000 | |
| -1,489,000 | |
| 1,492,000 | |
| 3,731,000 | |
| -2,451,000 | |
| -1,655,000 | |
| 5,969,000 | |
| -6,201,000 | |
| -1,199,000 | |
| -1,873,000 | |
| 1,634,000 | |
| -3,595,000 | |
| -1,099,000 | |
| -2,665,000 | |
| 4,646,000 | |
| -4,329,000 | |
| -3,292,000 | |
| -7,521,000 | |
| 9,231,000 | |
| -5,860,000 | |
| -1,269,000 | |
| -1,361,000 | |
| 974,000 | |
| -651,000 | |
| 7,766,000 | |
| -146,000 | |
| -553,000 | |
| -8,096,000 | |
| -2,772,000 | |
| -2,220,000 | |
| 72,725,000 | |
| -787,000 | |
| 1,219,000 | |
| -1,985,000 | |
| 2,932,000 | |
| -787,000 | |
| 557,000 | |
| -691,000 | |
| 1,163,000 | |
| 667,000 | |
| 234,000 | |
| -1,021,000 | |
| 339,480 | |
| 7,538 | |
| -35,751 | |
| -42,267 | |
| 17,298 | |
| 10,582 | |
| -5,260 | |
| -20,164 | |
| 16,192 | |
| 212 | |
| 15,069 | |
| -39,528 | |
| 21,972 | |
| 11,728 | |
| -13,003 | |
| -20,915 | |
| 23,565 | |
| 9,431 | |
| -3,172 | |
| -26,498 | |
| -1,109,121 | |
| 14,747 |